<DOC>
	<DOCNO>NCT01783002</DOCNO>
	<brief_summary>The overall sensitivity specificity 11C-MET PET/CT superior 18F-FDG PET/CT conventional SPECT-CT detection abnormal parathyroid gland .</brief_summary>
	<brief_title>11C Methionine PET Detection Hyperfunctional Parathyroid Tissues</brief_title>
	<detailed_description>STUDY OBJECTIVES Primary : To compare accuracy , sensitivity specificity 11C-methionine ( MET ) PET/CT 99mTc-MIBI SPECT-CT detection pathologic parathyroid glands patient primary hyperparathyroidism . Secondary : To compare accuracy , sensitivity specificity 11C-MET 18F-FDG PET/CT scan detection pathologic parathyroid glands patient primary hyperparathyroidism . STUDY DESIGN A phase II diagnostic imaging , single-centre study compare accuracy 11C-MET PET/CT standard 99mTc-MIBI SPECT-CT 18F-FDG PET/CT imaging patient primary hyperparathyroidism . STUDY POPULATION Number Subjects : 50 patient Number group : 1 : 50 primary hyperparathyroidism . Age/Gender : Age great equal 19 year / Male Female Study specific requirement : Subjects clinically suspect primary hyperparathyroidism require 99mTc-MIBI SPECT-CT parathyroid imaging . INVESTIGATIONAL PRODUCT Product : 11C-Methionine Route administration : Intravenous Dosage ( ) frequency : Radioactive dose 11C-Methionine 6 MBq per kilogram body weight per injection ( maximum dose 555 MBq ) ; one injection per patient . COMPARATOR PRODUCTS Product : 99mTc-Methoxyisobutylisonitrite ; 18F-Fluorodeoxyglucose Route administration : Intravenous Dosage ( ) frequency : ( 1 ) Radioactive dose 99mTc-Methoxyisobutylisonitrite 555 - 740 MBq per injection ; one injection per patient . ( 2 ) Radioactive dose 18F-Fluorodeoxyglucose 296 - 521 MBq per injection ; one injection per patient . EVALUATION CRITERIA Efficacy : The comparison accuracy , sensitivity , specificity 11C-MET PET/CT 99mTc-MIBI SPECT-CT 18F-FDG PET/CT detection pathologic parathyroid glands patient primary hyperparathyroidism . Safety : Vital sign follow 11C-MET administration ; adverse event collection .</detailed_description>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Primary</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Adults &gt; age 18 ; Able provide write informed consent ; Subjects biochemical evidence , include elevate serum calcium PTH level , primary hyperparathyroidism . Subjects previous successful parathyroidectomy parathyroid tissue reimplantation ; Pregnancy ; Subjects unable tolerate physical/logistical requirement complete two PET/CT scan , include lie still prolong period time receive two intravenous injection . Subjects exceed safe weight limit PET/CT bed ( 204.5 kg ) fit PET/CT machine ( diameter 70cm ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>